Is there treatment for traumatic optic neuropathy?

Area of Science:

• Ophthalmology
• Neurology
• Trauma Care

Background:

• Traumatic optic neuropathy (TON) can cause severe visual impairment.
• Significant controversy exists regarding optimal treatment strategies for TON.
• The current evidence base is limited, primarily comprising retrospective studies.

Purpose of the Study:

• To review current controversies in traumatic optic neuropathy (TON) treatment.
• To evaluate recent literature on therapeutic options for TON.
• To inform clinical decision-making for TON management.

Main Methods:

• Comprehensive literature review of studies on TON treatments.
• Analysis of evidence for corticosteroids, surgical decompression, and combined therapies.
• Assessment of studies investigating novel neuroprotective agents.

Main Results:

• No recent randomized controlled trials (RCTs) for TON interventions were identified.
• Observational studies suggest no significant visual outcome improvement with corticosteroids, surgery, or combined treatments compared to observation.
• Emerging research indicates potential diminished optic nerve functional reserve post-trauma and explores neuroprotective therapies like erythropoietin.

Conclusions:

• Absence of high-quality evidence (Class I) contributes to clinical consensus challenges in TON management.
• Current evidence does not support routine use of corticosteroids or surgical decompression for TON due to lack of demonstrated benefit and associated risks.
• Further research, including RCTs and investigation of neuroprotective agents, is needed to establish effective TON treatments.